Fig. 1 Intraganglionic injection. Paravertebral surgical exposure for intraganglionic injection, illustrating the operative field (left panel), reference diagram (middle panel), and cleaned vertebral bones (right panel). (a) Initial dissection of…
© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_32 32. AAV2-Neurturin for Parkinson’s Disease: What Lessons Have We Learned? Jeffrey H. Kordower1 (1) Department of Neurological Sciences, Rush…
Fig. 1 Overlapping AAV genome design and transduction. (a) The transgenic cassette, containing the depicted elements, is split into two separate vectors such that there is a homologous sequence overlap…
© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_30 30. Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders Dominic J. Gessler1 and Guangping Gao1 (1) University of…
Route of administration Advantages Disadvantages Intramuscular (IM) Noninvasive Requires retrograde transport of the vector; impractical to treat all skeletal muscles Intraparenchymal (IP) Delivery of therapeutic directly to location of interest…
© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_27 27. Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington’s Disease Deborah Young1 (1) Department of Pharmacology & Clinical Pharmacology…
Fig. 1 Representative images of mouse brain following systemic injection of AAV9 CB GFP. GFP immunofluorescence shows extensive GFP expression in neurons throughout multiple structures including the cortex (A), hippocampus…
Fig. 1 Transcriptional targeting of AAV vectors in the rat striatum. Exclusively neuronal transgene expression is shown after AAV-5-hSYN-EGFP transduction (left panel; shown is an overlay of green = EGFP fluorescence with…
© Springer Science+Business Media New York 2016Fredric P. Manfredsson (ed.)Gene Therapy for Neurological DisordersMethods in Molecular Biology138210.1007/978-1-4939-3271-9_23 23. Non-Viral, Lipid-Mediated DNA and mRNA Gene Therapy of the Central Nervous System (CNS): Chemical-Based Transfection James G. Hecker1 …
Optiprep 5 M NaCl 5×TD Water Final volume 15 % 45 ml 36 ml 36 ml 63 ml 180 ml 30 % 60 ml – 24 ml 36 ml…
